Sign in

Biancastella Cereser

@biancastellac.bsky.social
313 followers 695 following 18 posts

Cancer genetics at Imperial College London - working on #breastcancer and #coloncancer, and a mix and match of cool side projects

PostsRepliesMedia
Reposted by Biancastella Cereser
Graham Kendall @grahamkendall.bsky.social · 01/10/2026
You are the Editor-in-Chief and someone challenges a paper that was published five years ago. Is it your problem? buff.ly/DYVdccL
111
Reposted by Biancastella Cereser
The OncoAlert Network 🚨 @oncoalert.bsky.social · 30/09/2026
Why do some TNBC tumors respond to immunotherapy🧪 while others rapidly develop resistance? www.cell.com/cell-reports... A multi-omics analysis of advanced triple-negative breast cancer identifies predictors to chemo-immunotherapy and on-treatment dynamics
001
Reposted by Biancastella Cereser
Irving Institute for Cancer Dynamics @cancerdynamics.bsky.social · 12/08/2026
Welcome to the 2026-2027 Seminar Series! We are pleased to host researchers from institutions across the world, including @stanfordmedicine.bsky.social, @tcddublin.bsky.social, @harvardmed.bsky.social, and more > bit.ly/4waU5ue 📅 2nd Wednesdays @ 2PM ET | Schermerhorn Hall 603 & Zoom
image card of the 2026-2027 IICD seminar series, with headshots of each speaker
341
Reposted by Biancastella Cereser
EACR - European Association for Cancer Research @helloeacr.bsky.social · 08/06/2026
Today is the start of #EACR2026! We’re excited to welcome participants from over 70 countries to our Annual Congress here in Budapest. Find the programme at 2026.eacr.org and don’t forget to use the hashtag!
042
Biancastella Cereser @biancastellac.bsky.social · 10/04/2026
Very useful!
130
Reposted by Biancastella Cereser
Claudio Cantù @claudiocantu81.bsky.social · 10/04/2026
Register to The PALS Summer School in TranscriptOMICS 👉 Before April 15 And learn: Non-coding variants Prioritization based on 3D genomics epigenomics & advanced Transcription Factor analysis with AI by Dr. Artemy Zhigulev @ki.se @scilifelab.se @kawresearch.bsky.social @remeseiro-lab.bsky.social
032
Reposted by Biancastella Cereser
EACR - European Association for Cancer Research @helloeacr.bsky.social · 09/04/2026
Are you an early career researcher attending #EACR2026? You're invited to our early career showcase, Cancer Researchers to Watch! This opportunity is only available to researchers who register before the early registration deadline on 21 April. Make sure you're on the list! 2026.eacr.org/register
001
Biancastella Cereser @biancastellac.bsky.social · 09/04/2026
Cancer type-specific variation in patterns of driver alterations across 50,000 tumors: Cancer Cell www.cell.com/cancer-cell/...
cell.com
020
Biancastella Cereser @biancastellac.bsky.social · 26/03/2026
Clever way to discover AI-driver reviewers! www.nature.com/articles/d41...
nature.com
Major conference catches illicit AI use — and rejects hundreds of papers
The papers’ watermarks allowed organizers to detect use of large language models in peer review.
010
Biancastella Cereser @biancastellac.bsky.social · 15/03/2026
“Distance yourself from vague, coded or plainly unfair criticism, and stay open to feedback only from those you trust to act in good faith” 👏 www.nature.com/articles/d41...
nature.com
Cracked, but still there: the glass ceiling persists for senior women in science
To mark International Women’s Day on 8 March, Mangala Srinivas reminds junior colleagues that career success won’t protect you from gender-based bias.
021
Reposted by Biancastella Cereser
EACR - European Association for Cancer Research @helloeacr.bsky.social · 19/01/2026
Registration is OPEN for the cancer research community to join us for the #EACR2026 Congress! 🥳 Don't miss the opportunity to take advantage of our discounted early registration rate to attend, available until 21 April. 2026.eacr.org
01315
Reposted by Biancastella Cereser
Simon Fisher @profsimonfisher.bsky.social · 12/02/2026
One of my favourite things about this figure (sketched by Charles Darwin in one of his notebooks in 1837) is the “I think” at the top. Beyond an illustration of his evolving thoughts on descent with modification, the image somehow captures the essence of scientific curiosity. #DarwinDay 2026
Photograph of a page from Charles Darwin’s 1837 Notebook B showing the “Tree of Life” sketch, which gives a glimpse of his early insights into how a set of multiple related species might originate by divergence from a single starting point. The bottom shows a common root with various branches and twigs emerging from different nodes, with labels from A to D. There is a handwritten annotation at the top, reading “I think”. Further handwritten annotations on the right-hand side of the image are thought to state the following. “Case must be that one generation then should be as many living as now. To do this and to have many species in same genus (as is) requires extinction.”
54811
Reposted by Biancastella Cereser
UK Biobank @ukbiobank.ac.uk · 10/02/2026
✅ The UK Government has today granted access to half a million UK Biobank participants' coded GP data for health research. This change will dramatically increase the power of UK Biobank's dataset to advance the diagnosis, treatment and management of conditions handled by GPs.
12916
Reposted by Biancastella Cereser
Stefan Marciniak @profmarciniak.bsky.social · 28/01/2026
Has the MRC research funding ‘pause’ been covered by any major news network? It feels like it should be a major news story
82710
Reposted by Biancastella Cereser
IRB Barcelona @irbbarcelona.org · 28/01/2026
📢 We are #hiring! ▫️Head, Advanced Genomics Technologies Core Facility ▫️ Head, Histopathology Core Facility ▫️Engineering Officer ▫️ Pre-Award Officer ▫️ Senior Spatial #Omics Technician ...and many more!  ➡️ bit.ly/irbjobs #IRBJobs #ScienceJobs #JobOffer #JobOffers #OncoSky #AcademicSky
023
Reposted by Biancastella Cereser
EACR - European Association for Cancer Research @helloeacr.bsky.social · 23/01/2026
You have until 02 Feb to register for Next Generation Immunotherapies! Explore cutting-edge developments in immunotherapy, ranging from basic research to clinical applications, with a particular focus on innovative therapeutic strategies. Register from as little as €60: eacr.org/conference/n...
014
Reposted by Biancastella Cereser
Johanna Englund @johannaienglund.bsky.social · 20/01/2025
Are you working on #ECM or mechanobiology in the mammary gland or in breast cancer? Together with Jason Northey we are guest editing a collection on the topic for the Journal of Mammary gland biology and Neoplasia. Submission of articles is now open! link.springer.com/collections/...
Mammary tumor tissue stained with collagen (green) and nuclei (red)
0128
Reposted by Biancastella Cereser
EACR - European Association for Cancer Research @helloeacr.bsky.social · 21/01/2026
Explore how AI can be used to bridge chemistry, proteomics and precision medicine in our latest podcast episode with Bernhard Küster, who will be speaking at the 2026 EACR Congress. 🎧 Listen or read the transcript: magazine.eacr.org/using-ai-to-...
066
Reposted by Biancastella Cereser
Swiss National Science Foundation (SNSF) @snsf.ch · 16/01/2026
Career launchpad for researchers 🚀 As part of the Postdoc.Mobility funding scheme, the SNSF is supporting 214 postdocs to carry out a research project abroad or to return to Switzerland. The SNSF is providing 26.5 million Swiss francs for this purpose. 👉 sohub.io/5vq0
178
Reposted by Biancastella Cereser
Reschke lab @drrobinreschke.bsky.social · 16/01/2026
Fully funded Post-Doc @Heidelberg 🏰 Interested in cutting edge spatial biology methods 🗺️, computational biology 💻, cancer neuroscience 🧬, microbiome 🦠 and tumor immunology are encouraged to apply for projects 22 and 29. You can directly apply with me🤩 www.health-life-sciences.de/opportunitie...
health-life-sciences.de
HEALTH + LIFE SCIENCE ALLIANCE | Interinstitutional Postdocs
031
Reposted by Biancastella Cereser
Salah Elias @theeliaslab.bsky.social · 23/11/2024
I made a starter pack for mammary developmental and cancer biologists. Tell me if you want to be added or suggest colleagues. go.bsky.app/8ZbyV6c
82811
Reposted by Biancastella Cereser
The Company of Biologists @biologists.bsky.social · 09/01/2026
Journal of Cell Science @jcellsci.bsky.social is recruiting an enthusiastic and motivated Reviews Editor. An exciting opportunity for a talented scientific editor to make a contribution to an important journal in the field of #cellbiology. Deadline 2 Feb. More at: www.biologists.com/about-us/wor...
biologists.com
Work for us
Working for us We’re always looking for talented and motivated people to work as part of our close-knit team. Roles range from editorial to production, marketing to event co-ordination, HR to accounts...
01219
Biancastella Cereser @biancastellac.bsky.social · 08/01/2026
Very interesting read, especially on what are the repercussions of this increasing amount of fabricated papers
010
Reposted by Biancastella Cereser
Johanna Joyce @johannajoyce.bsky.social · 07/01/2026
Understanding why cancers relapse - sometimes years or decades after successful treatment - is a major challenge in the cancer field This perspective in Nature discusses several of the important recent advances and new studies in the field of tumor dormancy 🧪⚕️ www.nature.com/articles/d41...
nature.com
Why cancer can come back years later — and how to stop it
Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.
03923
Reposted by Biancastella Cereser
Nature Reviews Cancer @natrevcancer.nature.com · 02/01/2026
nature.com
Convergence of machine learning and genomics for precision oncology
Nature Reviews Cancer, Published online: 02 January 2026; doi:10.1038/s41568-025-00897-6In this Perspective, Reardon et al. explore how integrating machine learning into next-generation sequencing (NGS)-based molecular diagnostic workflows can enhance precision oncology. They discuss the benefits, challenges and responsible implementation of these approaches, highlighting their potential to streamline variant interpretation, maximize clinical insights and support more informed decision-making at the point-of-care.
063
Reposted by Biancastella Cereser
Susan G. Komen @susangkomen.bsky.social · 05/01/2026
Yes, it's true! Breast cancer can also affect men. Head to our website to learn everything you need to know about male breast cancer, from warning signs to support resources: bit.ly/43p0HJA
001
Reposted by Biancastella Cereser
María Bueno Álvez @buenoalvez.bsky.social · 12/10/2025
“A human pan-disease blood atlas of the circulating proteome” is out in Science! 🎉 Seeing this come together has been a highlight of my PhD: exploring proteome profiles across health, aging & disease. Huge thanks to all collaborators & patients 🙌 www.science.org/doi/10.1126/...
science.org
A human pan-disease blood atlas of the circulating proteome
The human blood proteome provides a holistic readout of health states through the assessment of thousands of circulating proteins. Here, we present a pan-disease resource to enable the study of divers...
193
Reposted by Biancastella Cereser
New Scientist @newscientist.com · 03/10/2025
Needle-free vaccines could be made possible by stretching the skin to stimulate immune cells and increase its permeability, then applying a lotion that contains the vaccine dose.
newscientist.com
Stretching the skin could enable vaccines to be given without a needle
091
Reposted by Biancastella Cereser
cniostopcancer.bsky.social @cniostopcancer.bsky.social · 24/09/2025
Last days!!! If you are a postdoc researcher from any nationality who wish to develop a project of excellence on any area of cancer research, apply for one of the four CNIO Friends Contracts at #CNIOStopCancer. Deadline:  September 28, 2025
bit.ly
New call for four "CNIO Friends" Postdoctoral Contracts
The Spanish National Cancer Research Centre (CNIO), thanks to our philanthropic initiative CNIO Friends, has opened a new call for four postdoctoral fellowships. Each fellowship will fully fund a three-year CNIO Friends research contract and are open to all areas of cancer research. Candidates –researchers from any nationality who wish to develop a research project […]
001
Reposted by Biancastella Cereser
Epigenome Technologies @epigenometech.bsky.social · 11/09/2025
Epigenetics Update - TET3 is a regulator and can be targeted for the intervention of myocardial fibrosis bit.ly/489VzfD #Epigenetics #DNADemthylation #HeartFailure #CardiacFibrosis #TET3 --- Discover the breakthrough at epigenometech.com
bit.ly
TET3 is a regulator and can be targeted for the intervention of myocardial fibrosis | EMBO Molecular Medicine
imageimageActivation of quiescent fibroblasts contributes to adverse ventricular remodeling following myocardial injuries, leading to heart failure. The DNA demethylase TET3 trans-activates the mechan...
022
Biancastella Cereser @biancastellac.bsky.social · 15/09/2025
It was indeed a pleasure to come and see the amazing research CRO is part of. Thank you and Dr Belletti for the warm welcome!
030
Reposted by Biancastella Cereser
Alecia-Jane Twigger @aj-twigger.bsky.social · 15/08/2025
Our next Cambridge Lactation Network Summer Symposium is coming again and we would love to see you! Register here 👇 #humanmilkscience #breastfeeding
011
Reposted by Biancastella Cereser
The Transmitter @thetransmitter.bsky.social · 13/08/2025
FlyBase, a Drosophila database, will lose a third of its team in early October because the Harvard grant that covered the employees’ salaries was canceled. Scientists warn that losing FlyBase could devastate fly research. By @claudia-lopez.bsky.social www.thetransmitter.org/community/ha...
thetransmitter.org
Harvard University lays off fly database team
The layoffs jeopardize this resource, which has served more than 4,000 labs for about three decades.
3123129
Biancastella Cereser @biancastellac.bsky.social · 14/08/2025
Fascinating read not just about the implication la of making your abstract sound “cool” but also about how this changes with authorship gender 🤔
020
Reposted by Biancastella Cereser
Barbara Marte @barbmarte.bsky.social · 14/08/2025
new out in Nature yesterday www.nature.com/articles/s41...
nature.com
Clone copy number diversity is linked to survival in lung cancer - Nature
A study presents ALPACA, a computational method for inferring clone- and allele-specific copy numbers of individual clones from multi-sample bulk DNA-sequencing data, and demonstrates its use to study...
073
Reposted by Biancastella Cereser
Karolinska Institutet @ki.se · 06/08/2025
A new study published in Modern Pathology reveals that the growth pattern of breast cancer tumors after neoadjuvant treatment can indicate the risk of recurrence. This insight is crucial for assessing patient prognosis 🧪 #BreastCancer #Oncology www.modernpathology.org/article/S089...
022
Reposted by Biancastella Cereser
Rhea Liang @liangrhea.bsky.social · 22/07/2025
Surprised to find only 21% of #BreastCancer in the UK is diagnosed via screening. The majority are diagnosed via symptoms and referral to '2 week clinic'. (Which I gather may be >2 weeks wait). The figure in Australia is 46%. Shouldn't the UK invest more in earlier (asymptomatic) detection? 🤔
Screenshot of graph with title 'Proportion of Cancer Cases by Route to Diagnosis England, 2020'. The relevant percentages for breast cancer are Two week clinic 59.8%, Screening 21%, other outpatient3%, GP referral 8.7%, emergency presentation 4.8%, unknown 1.8%.
6259
Reposted by Biancastella Cereser
Nature Communications @natcomms.nature.com · 23/07/2025
New featured image on our homepage! bit.ly/4kVZAY1 Related to this #OpenAccess article: The clinical and molecular landscape of #BreastCancer in women of African and South Asian ancestry bit.ly/4l3tN7G @qmbci.bsky.social Image credit: Niten Patel
Two women's torsos and a superimposed pink ribbon. Image credit: Niten Patel.
041
Reposted by Biancastella Cereser
Chris Tape @christophertape.bsky.social · 07/08/2025
We are recruiting! Our lab is looking for a new mass cytometry technician to help study colorectal cancer organoid perturbation experiments at scale. Please feel free to contact me with any questions! Full job description and application details here: www.ucl.ac.uk/work-at-ucl/...
043
Reposted by Biancastella Cereser
EACR - European Association for Cancer Research @helloeacr.bsky.social · 06/08/2025
Submissions are open for the EACR - @themarkfdn.bsky.social Postdoctoral Fellowships until 20 August! This funding is awarded for a period of three years to support excellent postdoctoral researchers in laboratories throughout Europe 🌍 Learn more: eacr.org/eacr-fellows...
068
Reposted by Biancastella Cereser
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 06/08/2025
#GastroEdPick Effect of gluten and wheat on symptoms and behaviours in adults with irritable bowel syndrome: a single-centre, randomised, double-blind, sham-controlled crossover trial. @lancetgastrohep.bsky.social www.sciencedirect.com/science/arti...
sciencedirect.com
Effect of gluten and wheat on symptoms and behaviours in adults with irritable bowel syndrome: a single-centre, randomised, double-blind, sham-controlled crossover trial
Many patients with irritable bowel syndrome (IBS) believe gluten or wheat triggers their symptoms. We compared symptomatic responses to wheat and glut…
031
Reposted by Biancastella Cereser
Nature Reviews Cancer @natrevcancer.nature.com · 22/07/2025
NEW content online!
nature.com
Environmental endocrine disruptors: rethinking the origins of early-onset ER+ breast cancer
Nature Reviews Cancer, Published online: 22 July 2025; doi:10.1038/s41568-025-00854-3Rising rates of early-onset oestrogen receptor-positive (ER+) breast cancer in women without genetic risk suggest a shift in disease biology. Endocrine-disrupting chemicals (EDCs) may accelerate tissue ageing, destabilize epigenetic regulation and impair immune surveillance. Chronic and cumulative EDC exposure may induce field cancerization in the breast, warranting urgent attention from researchers, regulators and public health leaders.
042
Reposted by Biancastella Cereser
CNAG @cnag-eu.bsky.social · 25/06/2025
📢 New genome for the Andean condor! 🦅A rare species — the world’s largest soaring bird — facing major threats like habitat loss, persecution & poisoning 🌎The work, led by IEGEBA (UBA-CONICET) with CNAG, opens new opportunities for its conservation 📎 onlinelibrary.wiley.com/doi/10.1111/...
101
Reposted by Biancastella Cereser
Anastasia Alataki @anastasiaalataki.bsky.social · 21/06/2025
Grateful to have been one of 30 women selected by @helloeacr.bsky.social to join the Women in Leadership workshop. Highlights included a powerful keynote by Prof. Caroline Dive and an inspiring discussion with Prof. @johannajoyce.bsky.social, @msmelanoma.bsky.social, Elaine Mardis, and Erica Sloan.
1102
Biancastella Cereser @biancastellac.bsky.social · 19/06/2025
Representing Imperial and our amazing (imho) studies at the #EACR25 @helloeacr.bsky.social ! @ninamoderau.bsky.social Anastasia Alataki in Lisbon 🍷☀️🧬
1133
Biancastella Cereser @biancastellac.bsky.social · 16/06/2025
Excited to be at #EACR in Lisbon with @ninamoderau.bsky.social and @anniebaker.bsky.social!!! ☀️🧬 Too much choice of excellent talks! #EACR2025 @helloeacr.bsky.social
040
Reposted by Biancastella Cereser
Silvia Ottaviani @silviaottaviani.bsky.social · 03/06/2025
🚨 pre-print alert 🚨 Very excited to share our work on how chomotherapy affects cell-to-cell communication. If you are interesting in #p53, #DNAdamage, #scRNA-seq have a read! Thanks to all authors 🤩 @biorxiv-cancer.bsky.social www.biorxiv.org/content/10.1...
biorxiv.org
Single-cell transcriptomics uncovers that cell-to-cell communication controls p53 activation
Conventional chemotherapy remains a cornerstone of cancer treatment and is highly effective in the adjuvant and neoadjuvant settings. However, therapeutic resistance, especially in the metastatic cont...
131
Reposted by Biancastella Cereser
EACR - European Association for Cancer Research @helloeacr.bsky.social · 09/05/2025
One month left to register for the 2025 Early Career Researchers Conference! In its fifth edition, this virtual conference has become a must-attend for early career researchers to discuss critical aspects of a scientific career in cancer research. Don't miss it: eacr.org/conference/e...
068
Reposted by Biancastella Cereser
Trevor Graham @trevorgraham.bsky.social · 22/05/2025
Single cell whizz with green fingers for molecular genomics? Want to develop and apply new technologies for profiling #cancer #evolution? Like single cell WGS + ATAC: www.biorxiv.org/content/10.1... Perhaps our senior scientific officer role is for you? jobs.icr.ac.uk/vacancies/12... @icr.ac.uk
jobs.icr.ac.uk
Higher or Senior Scientific Officer in Sutton | The Institute of Cancer Research
View details and apply for this Higher or Senior Scientific Officer vacancy in Sutton. Salary : Salary from 39,805 to 49,023 Reporting to: Prof Trevor Graham Duration of ...
154
Biancastella Cereser @biancastellac.bsky.social · 23/05/2025
Hoping that peer-reviewers don’t rely on AI to review these papers…. 😕
nature.com
AI linked to explosion of low-quality biomedical research papers
Analysis flags hundreds of studies that seem to follow a template, reporting correlations between complex health conditions and single variables based on publicly available data sets.
010